Compare Cardinal Health Inc (CAH) vs EHang Holdings Ltd - ADR (EH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs EHang Holdings Ltd - ADR — how do they compare? Cardinal Health Inc trades at $228.8 (market cap $53.89B), while EHang Holdings Ltd - ADR trades at $5.52 (market cap $413.36M). The key difference: Cardinal Health Inc is far larger — about 130.4× EHang Holdings Ltd - ADR's market cap, and Cardinal Health Inc pays a 0.89% dividend while EHang Holdings Ltd - ADR pays none. Which is the better fit depends on your goals.
| CAH | EH | |
|---|---|---|
Market Cap | $53.89B | $413.36M |
Sector | Health | Industrials |
52-Week High | $239.71 | $19.99 |
52-Week Low | $146.04 | $5.41 |
Enterprise Value | $58.87B | $353.02M |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
EHang Holdings (EH) trades at $5.41, down 3.22% on the day, reflecting ongoing volatility in the advanced air mobility sector. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal persistent losses with a net margin of -77.56% in 2025 despite a gross margin of 61.53%. Recent Q1 2026 earnings beat expectations but highlighted a sharp quarterly revenue drop, underscoring execution challenges amid expansion efforts.
The outlook remains high-risk with mixed analyst sentiment; a $6.97 consensus target suggests modest upside, but deep losses and cash burn necessitate careful monitoring of commercialization progress. Key risks include operational scalability, regulatory hurdles, and intense competition in the emerging eVTOL market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About EHang Holdings Ltd - ADR
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →
